Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.

Biotechnology

Pharmaceutical

Yamo Pharmaceuticals' headquarters in New York, NY, United States

This department oversees the organization's strategic direction and overall management.

This department manages compliance with regulatory standards and oversees quality assurance in clinical research operations.

This department manages the organization's financial planning, analysis, and reporting functions.